Sangamo Therapeutics earnings missed by $0.11, revenue fell short of estimates
NegativeFinancial Markets

Sangamo Therapeutics earnings missed by $0.11, revenue fell short of estimates
Sangamo Therapeutics reported earnings that fell short by $0.11, alongside revenue that did not meet expectations. This news is significant as it highlights ongoing challenges for the company in achieving financial targets, which could impact investor confidence and future funding opportunities.
— via World Pulse Now AI Editorial System





